pDONR223_KRAS_p.G13D Citations (1)
Originally described in: High-throughput Phenotyping of Lung Cancer Somatic Mutations.Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, Bagul M, Kamburov A, Imielinski M, Hogstrom L, Zhu C, Yang X, Pantel S, Sakai R, Watson J, Kaplan N, Campbell JD, Singh S, Root DE, Narayan R, Natoli T, Lahr DL, Tirosh I, Tamayo P, Getz G, Wong B, Doench J, Subramanian A, Golub TR, Meyerson M, Boehm JS Cancer Cell. 2016 Aug 8;30(2):214-28. doi: 10.1016/j.ccell.2016.06.022. Epub 2016 Jul 28. PubMed Journal
Articles Citing pDONR223_KRAS_p.G13D
| Articles |
|---|
| Intrinsic resistance to RAS inhibitors is driven by dysregulation of KRAS degradation. Ivanisevic T, Ma Y, Van Boxel E, Magits W, Lechat B, Kocberber Z, Willnow P, Fendt SM, Velde GV, Sewduth R, Sablina AA. Nat Commun. 2025 Dec 15;17(1):411. doi: 10.1038/s41467-025-67109-5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.